1. Home
  2. OGEN vs UCAR Comparison

OGEN vs UCAR Comparison

Compare OGEN & UCAR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Oragenics Inc.

OGEN

Oragenics Inc.

HOLD

Current Price

$0.64

Market Cap

2.7M

Sector

Health Care

ML Signal

HOLD

Logo U Power Limited

UCAR

U Power Limited

HOLD

Current Price

$1.53

Market Cap

3.1M

ML Signal

HOLD

Company Overview

Basic Information
Metric
OGEN
UCAR
Founded
1996
2013
Country
United States
China
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Retail-Auto Dealers and Gas Stations
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
2.7M
3.1M
IPO Year
2010
2022

Fundamental Metrics

Financial Performance
Metric
OGEN
UCAR
Price
$0.64
$1.53
Analyst Decision
Strong Buy
Analyst Count
0
1
Target Price
N/A
$50.00
AVG Volume (30 Days)
45.1K
20.1M
Earning Date
05-11-2026
05-15-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.11
$0.04
52 Week High
$9.16
$4.98

Technical Indicators

Market Signals
Indicator
OGEN
UCAR
Relative Strength Index (RSI) 47.91 52.12
Support Level $0.61 $1.29
Resistance Level $1.02 $1.71
Average True Range (ATR) 0.05 0.35
MACD 0.00 -0.03
Stochastic Oscillator 29.60 24.82

Price Performance

Historical Comparison
OGEN
UCAR

About OGEN Oragenics Inc.

Oragenics Inc is a development-stage biopharmaceutical company dedicated to the research and development of nasal delivery pharmaceutical therapies targeting neurological conditions and infectious diseases. The Company is currently focused on advancing the development and commercialization of its product candidate, ONP-002. ONP-002 is a fully synthetic, non-naturally occurring neurosteroid that is lipophilic and is designed to cross the blood-brain barrier, with the goal of reducing swelling, oxidative stress, and inflammation while restoring proper blood flow through gene amplification. The Company's primary focus is on the development and commercialization of ONP-002 for the treatment of mild traumatic brain injury (mTBI), or concussion.

About UCAR U Power Limited

U Power Ltd is involved in the provision of vehicle sourcing services. It is principally engaged in the provision of new energy vehicles development and sales; battery swapping stations manufacturing and sales; battery swapping services, and sourcing services. The company, as a broker, engaged in sales of vehicles between automobile wholesalers and buyers, including small and medium-sized vehicle dealers and individual customers located in lower-tier cities in China.

Share on Social Networks: